October 04, 2024

Epilepsy Linked to Heart Risks in Seniors

A recent study reveals that older adults with a history of epilepsy face a heightened risk of cardiovascular events, with medication use playing a significant role in this association.

Conexiant

October 04, 2024

Light Therapy Brightens Outlook for Depression Treatment

A meta-analysis of 11 trials found that bright light therapy significantly improved remission rates in nonseasonal depression, with 40.7% of patients achieving remission compared to 23.5% in control groups.

Conexiant

October 04, 2024

Patient-Centered Approach to Medication Deprescribing

Mailing educational brochures before appointments led to a 29.5% deprescribing rate, compared to 25.8% in controls, suggesting a simple intervention can significantly shift medication management.

Conexiant

October 04, 2024

Single and Happy? Thank Your Friends

Study reveals 37.9% of single emerging adults are relatively happy, challenging stereotypes and highlighting the crucial role of friendship satisfaction in their well-being.

Conexiant

October 04, 2024

Fathers' Mental Health Improves with Group Therapy: Study

A cluster randomized trial found that a group parenting intervention for fathers with postpartum depression led to significant improvements in paternal mental health and child social-emotional development, with 75% of participants attending 10 or more of the 12 sessions.

Conexiant

October 03, 2024

Antidepressant Prescribing Patterns Linked to Clinicians

Clinicians treating major depressive disorder exhibit marked variability in prescribing patterns and patient outcomes, with dropout rates ranging from 27% to 69% across different clinician clusters.

Conexiant

October 03, 2024

Sedentary Time Cut Helps Prevent Pain Increase: Study

In adults with metabolic syndrome, reducing sedentary time by 40 minutes per day prevented the worsening of back pain over 6 months, while pain intensity approximately doubled in the control group.

Conexiant

October 03, 2024

High-Dose Antipsychotics Raise Pneumonia Risk

High-dose quetiapine (≥440 mg/d) was associated with the highest risk of pneumonia (AHR, 1.78) among antipsychotics in patients with schizophrenia, challenging previous beliefs about clozapine's singular risk profile.

Conexiant

October 02, 2024

Higher Adjusted Odds of 90-Day Readmissions in Neonatal Opioid Withdrawal Syndrome Infants

New research led by Julie R. Gaither, PhD, MPH, RN from the Yale School of Medicine reveals that infants with neonatal opioid withdrawal syndrome have an 18% higher risk of hospital readmission and are at increased risk of trauma and maltreatment.

Conexiant